It made it possible to identify covid-19. Now, this genetic technique is helping doctors make life-or-death decisions.
AI Brief
Your highlights
Image source, Getty ImagesImage caption, Hundreds of pathogens can cause illnesses such as pneumonia or sepsis. By David CoxTitle, BBC Future*Published 24 minutes agoReading time: 7 minIn late December 2019, a team of virologists from three major Chinese cities began analyzing samples obtained via swabs from hospitalized patients with mysterious cases of severe pneumonia. All of them had been at the Huanan seafood market in Wuhan before falling rapidly ill. However, when analyzing the samples, the virologists got no conclusive results: the genetic material did not match any previously discovered pathogen. The doctors turned to a new detection method known as metagenomic analysis. Instead of looking for already known microbes, this test makes it possible to identify all the microorganisms present in the samples, both those that had already been described and those that had not. Thanks to this, they were able to observe that the pathogen found in the patients' samples bore a great similarity to the coronavirus family, a group that includes viruses that in the past had caused outbreaks of severe pneumonia in humans, such as Middle East respiratory syndrome (MERS). The scientists had just discovered covid-19."It marked a turning point compared with previous pandemics," says Niranjan Nagarajan, an associate professor at the National University of Singapore. Identifying the pathogen made it possible to quickly develop diagnostic tests for covid-19 in order to try to curb its spread, and it kicked off a frantic worldwide search for treatments and vaccines. To date, this remains the best-known use of metagenomics. However, this technique is increasingly being used in hospitals. From the rapid diagnosis of sepsis to identifying the causes of unexplained ailments, it is already saving lives. Revealing the unknownWhen a patient arrives at a neurology unit showing signs of confusion and drowsiness, along with fever, headache and weakness, doctors are fully aware that it could be a life-or-death emergency. Skip Most read and continue readingMost readEnd of Most readThis set of symptoms can indicate meningitis or encephalitis, potentially fatal conditions that affect the brain and spinal cord. However, doctors often face a critical dilemma. The most appropriate treatment would depend on whether the patient's condition is due to a virus, a bacterium, or an overreaction of the brain's immune system. Nevertheless, faced with a shortage of time and diagnostic tests, doctors are frequently forced to act with caution, covering several possibilities at once."A decision has to be made immediately," says Charles Chiu, a professor and infectious disease expert in the Department of Medicine at the University of California, San Francisco (US), who has been conducting new studies on the use of metagenomic testing. "Currently, when treating critically ill patients, doctors treat them both for a possible infection and for an autoimmune disease." Image source, Getty ImagesImage caption, When a patient arrives at the hospital in critical condition, doctors must make a decision immediately. In a way, this is contradictory, as it involves suppressing the patient's immune system even though they might be suffering from an infection. "But often there is no other option," notes Chiu. Metagenomics is now helping to guide these decisions. Chiu and his colleagues have developed a pioneering metagenomic test to identify pathogens in cerebrospinal fluid, the fluid that bathes the brain and spinal cord. This test has already uncovered cases in which, unbeknownst to the doctors, a pathogen was the cause of the patient's symptoms. For example, Chiu treated a patient diagnosed with meningitis and liver failure, for whom a liver transplant was scheduled. However, the metagenomic test performed on her cerebrospinal fluid revealed that she actually had an infection with the hepatitis E virus. Although hepatitis E is a known and treatable cause of liver disease, it is not usually included in routine diagnostic tests in high-income countries such as the United States."We gave her an antiviral medication, her condition improved, and we prevented her from having to undergo the transplant," explains Chiu. Image source, Getty ImagesImage caption, Hepatitis E is difficult to diagnose because its symptoms can overlap with those of other illnesses. Until recently, the use of metagenomics was limited by the time needed to perform the analysis. Separating human DNA from microbial DNA, as well as identifying clues of a potentially concerning pathogen, requires highly specialized skills. "Carrying out the sequencing and analysis can take from several days up to a week," notes Nagarajan. "The patient could die before a result is obtained." Today, however, there are machines capable of sequencing DNA in just one or two hours, and artificial intelligence tools that can process massive datasets to decipher the patterns they contain. This is finally making metagenomics far more accessible. A race against timeFor people with malfunctioning immune systems, any infection can quickly become a potentially deadly threat. Transplant recipients, cancer patients undergoing immunosuppressive treatments, and those living with autoimmune diseases must remain on constant high alert. Studies have suggested that immunocompromised patients who develop sepsis or blood poisoning due to an infection have a 23% higher risk of dying in the hospital. However, making a rapid diagnosis in these cases is not always straightforward."Illnesses such as pneumonia or sepsis can be caused by hundreds of potential pathogens, which results in a very long diagnostic odyssey in which we have to send test after test," says Chiu. "It can be a race against time." In Singapore, Nagarajan leads a project to see whether AI-enhanced metagenomic detection can lead to faster, more targeted treatment for immunocompromised people. Image source, Getty ImagesA typical dataset, says Chiu, is riddled with spurious information. This includes the seemingly harmless viruses that most people carry and laboratory microbes that have accidentally contaminated the sample. AI can help with this by sorting through metagenomic datasets, making it faster and easier for doctors to get an idea of what is going on. A patient might also have multiple co-infections, of which only one is making them ill, or the damage could be related to an autoimmune response and not related to a pathogen at all. AI can help identify which pathogens are causing the damage by analyzing how the person's genes are expressed, such as which proteins they are producing. This can be used to determine whether a patient's immune system is likely fighting a virus or happily coexisting with it."(This) gives us the ability to do precision medicine... which will allow us to personalize or tailor the optimal treatment," says Chiu. Transforming public healthAs data on the effectiveness of metagenomics is gathered, it could play an increasingly important role in hospitals. Last year, for example, a pilot study conducted at two London hospitals examined whether metagenomics could provide additional information about hospitalized patients with respiratory infections. It was found that, in 30% of cases, these tests could identify pathogens that are not detected by conventional methods. In one particular case, the test spared a patient from having to undergo invasive surgery: they had tuberculosis, not lung cancer, as had initially been assumed. The test also detected two cases of the respiratory virus parvovirus B19. This occurred months before UK and European agencies issued public health alerts about its growing prevalence, suggesting that metagenomics could serve to warn authorities about emerging epidemics. Indeed, Nagarajan notes that several laboratories in Singapore are currently conducting metagenomic analyses of wastewater and air samples. The data is then processed by artificial intelligence models trained to detect signs of new viruses, as part of efforts to prevent the next pandemic. Proactive surveillance could similarly have served as an early warning for covid-19. In Italy, wastewater analysis revealed traces of the virus months before the first cases in the country were confirmed. Download the new BBC World Service app. Choose BBC News Mundo and receive news alerts, documentaries and analysis, all in one place. Important: the new app is not available in the UK or the United States. You can also follow us on YouTube, Instagram, TikTok, Facebook, X and our WhatsApp channel. And don't forget to subscribe here to our newsletter to receive a special selection of our best content every Friday.